How to Expand Your Nuclear Cardiac Program

Intermountain’s Healthcare Experience:

It can be a large undertaking to bring cardiac PET to your institution — but the return on this investment in time and resources can be significant.

Impact of cardiac PET at Intermountain:

• Virtual elimination of false negatives and false positives for improved clinical confidence.
• Volumes of 16-17 patients per day on average to support the PET service line.
• Ability to conduct four studies in one table setting for better workflow and efficiency.

Intermountain Healthcare is a nonprofit system of 22 hospitals serving patients in Utah and southeastern Idaho. Recently, it successfully expanded its nuclear cardiac program to include cardiac PET.

Should you invest in cardiac PET? Here’s what you need to know.

Learn the strategies Intermountain Health used to successfully expand its nuclear cardiac program to include cardiac PET. Watch here to learn more.

Clinical Impact

Providing information to cardiologists to help them eliminate unnecessary diagnostic cardiac catheterizations to focus on revascularization therapies. Ability to do more percutaneous coronary interventions in the cath lab during the same time period.

Operational Impact

Ability to re-task the cardiac catheterization lab to focus on revascularization therapies for better efficiency. Improved clinical accuracy supports cardiac PET volumes of 16-17 patients per day in a 10-hour period, which maintains a profitable service line.

“With cardiac PET, we’re using fewer resources, and spending fewer healthcare dollars on unnecessary tests, to determine which patients have true coronary artery disease.” Kent Meredith, CV Medical Director, Nuclear Cardiology, SPECT/PET Services, Intermountain Heart Institute, Intermountain Medical Center.”